approval · primary record
ESTRADIOL
3 approval events · latest 2026-05-19
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-05-19 |
| Approval events | 3 |
| Brand | ESTROGEL |
| Sponsor | ASCEND THERAPS US |
| Route | TRANSDERMAL |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-05-19 | FDA | NDA | ESTROGEL | ASCEND THERAPS US | TRANSDERMAL |
| 2026-02-12 | FDA | NDA | DIVIGEL | VERTICAL PHARMS | TRANSDERMAL |
| 2025-05-05 | FDA | NDA | ALORA | ABBVIE | TRANSDERMAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:27:56.384Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:estradiol
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Estradiol · compound